Shares of Endologix (ELGX) Turn Positive Following Lazard Upgrade
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Endologix (NASDAQ: ELGX) shares have jumped into positive territory over the last few minutes of trade as an analyst at Lazard Capital just upgraded the stock from Neutral to Buy. The analyst set a new $11 price target.
With Endologix shares now up 2 percent to $8.71, Lazard's new price target represents possible upside of about 26 percent.
For more ratings news on Endologix click here and for the rating history of Endologix click here.
With Endologix shares now up 2 percent to $8.71, Lazard's new price target represents possible upside of about 26 percent.
For more ratings news on Endologix click here and for the rating history of Endologix click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macquarie Double Upgrades Kinsus Interconnect Technology Corp (3189:TT) to Outperform
- Deutsche Bank Upgrades Mediobanca Banca di Credito Finanziario SpA (MB:IM) to Buy
- Itau BBA Upgrades AGI Inc (AGBK) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
